Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma

Clinical Cancer Research

Volumn 5, Issue 1, 1999, Pages 17-23

  Shivapurkar, Narayan ^a   Virmani, Arvind K ^a   Wistuba, Ignacio I ^a   Milchgrub, Sara ^a   Mackay, Bruce ^b   Minna, John D ^a   Gazdar, Adi F ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; B LYMPHOBLAST; CHROMOSOME DELETION 4; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOBLASTOID CELL; MALIGNANT MESOTHELIOMA; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 4; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MESOTHELIOMA; MICROSATELLITE REPEATS; PARAFFIN EMBEDDING; TUMOR CELLS, CULTURED;

EID: 0032900984     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mossman, B. T., Bignon, J., Corn, M., Seaton, A., and Gee, J. B. Asbestos: scientific developments and implications for public policy. Science (Washington DC), 247: 294-301, 1990.
2. Muscat, J. E., and Wynder, E. L. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res., 51: 2263-2267, 1991.
3. Antman, K. H., Schiff, P. B., and Pass, H. I. Benign and malignant mesothelioma. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Benign and Malignant Mesothelioma, pp. 1853-1878. Philadelphia: Lippincott, 1997.
4. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
5. Knudson, A. G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res., 45: 1437-1443, 1985.
6. Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y., and Testa, J. R. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas. Cancer Res., 53: 4761-4763, 1993.
7. Lu, Y. Y., Jhanwar, S. C., Cheng, J. Q., and Testa, J. R. Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma. Genes Chromosomes Cancer, 9: 76-80, 1994.
8. Bianchi, A. B., Mitsunaga, S. I., Cheng, J. Q., Klein, W. M., Jhanwar, S. C., Seizinger, B., Kley, N., Klein-Szanto, A. J., and Testa, J. R. High . frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. Natl. Acad. Sci. USA, 92: 10854-10858, 1995.
9. Lee, W. C., Balsara, B., Liu, Z., Jhanwar, S. C., and Testa, J. R. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res., 56: 4297-4301, 1996.
10. Brown, R. W., Clark, G. M., Tandon, A. K., and Allred, D. C. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum. Pathol., 24: 347-354, 1993.
11. Weiss, L. M., and Battifora, H. The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma. Hum. Pathol., 24: 345-346, 1993.
12. Buetow, K. H., Murray, J. C., Israel, J. L., London, W. T., Smith, M., Kew, M., Blanquet, V., Brechet, C., Redeker, A., and Govindarajah, S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 86: 8852-8856, 1989.
13. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989.
14. Polascik, T. J., Cairns, P., Chang, W. Y., Schoenberg, M. P., and Sidransky, D. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res., 55: 5396-5399, 1995.
15. Hammoud, Z. T., Kaleem, Z., Cooper, J. D., Sundaresan, R. S., Patterson, G. A., and Goodfellow, P. J. Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res., 56: 4499-4502, 1996.
16. Larson, A. A., Liao, S. Y., Stanbridge, E. J., Cavenee, W. K., and Hampton, G. M. Genetic alterations accumulate during cervical tumor-igenesis and indicate a common origin for multifbcal lesions. Cancer Res., 57: 4171-4176, 1997.
17. Loughran, O., Clark, L. J., Bond, J., Baker, A., Berry, I. J., Edington, K. G., Ly, I. S., Simmons, R., Haw, R., Black, D. M., Newbold, R. F., and Parkinson, E. K. Evidence for the inactivation of multiple replicative life span genes in immortal human squamous cell carcinoma keratinocytes. Oncogene, 14: 1955-1964, 1997.
18. Pershouse, M. A., El-Naggar, A. K., Hurr, K., Lin, H., Yung, W. K., and Steck, P. A. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene, 14: 369-373, 1997.
19. Pershouse, M. A., Ligon, A. H., Pereira-Smith, O. M., Killary, A. M., Yung, W. K., and Steck, P. A. Suppression of transformed phenotype and tumorigenicity after transfer of chromosome 4 into U251 human glioma cells. Genes Chromosomes Cancer, 20: 260-267, 1997.
20. Hagemeijer, A., Versnel, M. A., Van Drunen, E., Moret, M., Bouts, M. J., van der Kwast, T. H., and Hoogsteden, H. C. Cytogenetic analysis of malignant mesothelioma. Cancer Genet. Cytogenet., 47: 1-28, 1990.
21. Levin, N. A., Brzoska, P. M., Wamock, M. L., Gray, J. W., and Christman, M. F. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes Cancer, 13: 175-185, 1995.
22. Petersen, I., Langreck, H., Wolf, G., Schwendel, A., Psille, R., Vogt, P., Reichel, M. B., Ried, T., and Dietel, M. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br. J. Cancer, 75: 79-86, 1997.
23. Petersen, I., Bujard, M., Petersen, S., Wolf, G., Goeze, A., Schwendel, A., Langreck, H., Geliert, K., Reichel, M., Just, K., du Manoir, S., Cremer, T., Dietel, M., and Ried, T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res., 57: 2331-2335, 1997.
24. Virmani, A. K., Fong, K. M., Kodagoda, D., Mclntire, D., Hung, J., Tonk, V., Minna, J. D., and Gazdar, A. F. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer, 21: 308-319, 1998.
25. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 558-563, 1995.
26. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J. The 1993-94 Genethon human genetic linkage map. Nat. Genet., 7: 246-339, 1994.
27. Wistuba, I.I., Behrens, C., Milchgrub, S., Virmani, A. K., Jagirdar, J., Thomas, B., Joachim, H. L., Litzky, L. A., Brambilla, E. M., Minna, J. D., and Gazdar, A. F. Comparison of molecular changes in lung cancers arising in HIV positive and HIV indeterminate subjects. J. Am. Med. Assoc., 279.- 1554-1559, 1998.
28. Don, R. H., Cox, P. T., Wainwright, B. J., Baker, K., and Mattick, J. S. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res., 19: 4008, 1991.
29. Sekido, Y., Pass, H. I., Bader, S., Mew, D. J., Christman, M. F., Gazdar, A. F., and Minna, J. D. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res., 55: 1227-1231, 1995.
30. Bjorkqvist, A. M., Tammilehto, L., Nordling, S., Nurminen, M., Anttila, S., Mattson, K., and Knuutila, S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and largecell anaplastic carcinoma of the lung. Br. J. Cancer, 77: 260-269, 1998.